title: Large-scale genome projects enter the clinic on both sides of the Atlantic.
authors.forename: Rabiya S
authors.initials: RS
authors.lastname: Tuma
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology; D014408:Biomarkers, Tumor / Q000235:genetics*; D002173:Cancer Care Facilities; D058534:Class I Phosphatidylinositol 3-Kinases; D004345:Drug Industry / Q000639:trends; D066246:ErbB Receptors / Q000235:genetics; D005820:Genetic Testing / Q000379:methods; D015894:Genome, Human / Q000235:genetics; D005838:Genotype; D006801:Humans; D058990:Molecular Targeted Therapy; D009154:Mutation; D009313:National Health Programs; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D009426:Netherlands; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics; D017422:Sequence Analysis, DNA / Q000379:methods; D006113:United Kingdom; D014481:United States
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D019869:Phosphatidylinositol 3-Kinases; D058534:Class I Phosphatidylinositol 3-Kinases; C484760:PIK3CA protein, human; D066246:ErbB Receptors